Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic

Updated on: January 08,2024

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic

Updated on:January 08,2024

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on: January 11,2024

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on:January 11,2024

New drug to supercharge immune cells in the fight against cancer

by Jess Reid,University of Western AustraliaKiller T cells surround a cancer cell. Credit: NIHA new cancer treatment with the ability to normalise tumour blood vessels and boost the body's i

Updated on: March 26,2024

New drug to supercharge immune cells in the fight against cancer

by Jess Reid,University of Western AustraliaKiller T cells surround a cancer cell. Credit: NIHA new cancer treatment with the ability to normalise tumour blood vessels and boost the body's i

Updated on:March 26,2024

New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma

Updated on: March 30,2025

New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma

Updated on:March 30,2025

Blood pressure drug may prevent immunotherapy-induced brain swelling in patients with glioblastoma

byMassachusetts General HospitalICB increases GBM vascular leakage and induces brain edema. MR T2-weighted-Fluid-Attenuated Inversion Recovery (T2-FLAIR) images obtained from a recurrent GBM pat

Updated on: December 26,2023

Blood pressure drug may prevent immunotherapy-induced brain swelling in patients with glioblastoma

byMassachusetts General HospitalICB increases GBM vascular leakage and induces brain edema. MR T2-weighted-Fluid-Attenuated Inversion Recovery (T2-FLAIR) images obtained from a recurrent GBM pat

Updated on:December 26,2023

Improving melanoma diagnostic tools

by QIMR Berghofer Medical Research InstituteAge-standardized melanoma incidence from 1982 through 2018 in the U.S. White, Queensland, and Scotland populations. Joinpoint regression models for in situ

Updated on: December 22,2023

Improving melanoma diagnostic tools

by QIMR Berghofer Medical Research InstituteAge-standardized melanoma incidence from 1982 through 2018 in the U.S. White, Queensland, and Scotland populations. Joinpoint regression models for in situ

Updated on:December 22,2023

Aspirin could increase survival in cancer

byThe Royal SocietyCredit: Unsplash/CC0 Public DomainDoes aspirin increase survival in cancer patients? UK researchers say that despite the smaller side-effects of aspirin, taking the drug has a

Updated on: December 18,2023

Aspirin could increase survival in cancer

byThe Royal SocietyCredit: Unsplash/CC0 Public DomainDoes aspirin increase survival in cancer patients? UK researchers say that despite the smaller side-effects of aspirin, taking the drug has a

Updated on:December 18,2023

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on: July 17,2024

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on:July 17,2024

Military probing whether cancers linked to nuclear silo work

by Tara CoppAn inert Minuteman III missile is seen in a training launch tube at Minot Air Force Base, N.D., June 25, 2014. Nine military officers who had worked decades ago at a nuclear missile base i

Updated on: December 26,2023

Military probing whether cancers linked to nuclear silo work

by Tara CoppAn inert Minuteman III missile is seen in a training launch tube at Minot Air Force Base, N.D., June 25, 2014. Nine military officers who had worked decades ago at a nuclear missile base i

Updated on:December 26,2023

Scientists develop new targeted therapeutic strategies to fight liver metastasis

by Qiu Rong, University of Science and Technology of ChinaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI157937The research group led by Prof. Zeng Zhu

Updated on: December 27,2023

Scientists develop new targeted therapeutic strategies to fight liver metastasis

by Qiu Rong, University of Science and Technology of ChinaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI157937The research group led by Prof. Zeng Zhu

Updated on:December 27,2023

Metabolic health may play role in obesity-related cancers

byLund UniversityHazard ratios (95% confidence interval) of all obesity-related cancers and common cancer forms in 400 111 men according to combinations of metabolic health status and body mass

Updated on: December 20,2023

Metabolic health may play role in obesity-related cancers

byLund UniversityHazard ratios (95% confidence interval) of all obesity-related cancers and common cancer forms in 400 111 men according to combinations of metabolic health status and body mass

Updated on:December 20,2023

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Updated on: December 02,2024

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Updated on:December 02,2024